Sage Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSage Therapeutics

Sage Therapeutics(SAGE)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Apomorphine	Apomorphine	2022-02-23	2023-2036	Parkinson disease , Erectile dysfunction
Chlorhexidine	Chlorhexidine	2005-04-25	2024-2027	Periodontal diseases , Infectious skin diseases , Gram-negative bacterial infections , Oral candidiasis , Gram-positive bacterial infections , Hypercholesterolemia , Coronary artery disease , Hypertriglyceridemia , Hyperlipoproteinemias
Zulresso	Brexanolone	2019-06-17	2029-2037	Postpartum depression

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

psychotic disorders

,

mental disorders

,

,

essential tremor

,

,

alcohol drinking

,

traumatic stress disorders

,

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

post-traumatic stress disorders

,

postpartum depression

,

,

depressive disorder

,

wounds and injuries

,

attention deficit disorder with hyperactivity

Chlorhexidine gluconate

,

healthy volunteers/patients

,

catheterization

,

communicable diseases

,

,

,

tissue adhesions

,

ventilator-associated pneumonia

,

wounds and injuries

,

catheterization

,

,

communicable diseases

,

,

,

healthy volunteers/patients

,

ventilator-associated pneumonia

,

wounds and injuries

,

multiple myeloma

Cetylpyridinium chloride

ventilator-associated pneumonia

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

insulin resistance

breast neoplasms

,

head and neck neoplasms

,

,

,

glandular and epithelial neoplasms

,

healthy volunteers/patients

,

,

clostridium infections

,

clostridioides difficile

,

,

postoperative pain

,

,

drug resistant epilepsy

,

,

,

consciousness disorders

,

general anesthesia

,

postpartum depression

Histone-arginine methyltransferase carm1

healthy volunteers/patients

,

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

non-hodgkin lymphoma

,

,

non-small-cell lung carcinoma

,

liver neoplasms

,

urologic neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

diabetes mellitus

,

rheumatoid arthritis

,

kidney diseases

,

kidney transplantation

,

breast neoplasms

,

,

,

hepatocellular carcinoma

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

esophageal neoplasms

,

biliary tract neoplasms

,

rectal neoplasms

,

,

small cell lung carcinoma

,

castration-resistant prostatic neoplasms

,

,

,

type 2 diabetes mellitus

,

,

brain neoplasms

,

hematologic neoplasms

,

lymphoproliferative disorders

,

neoplasms by histologic type

,

neoplasms by site

,

multiple myeloma

,

plasma cell neoplasms

,

colorectal neoplasms

,

,

disability evaluation

,

cognition disorders

,

,

,

,

chronic hepatitis b

,

chronic hepatitis

,

,

,

multiple sclerosis

,

,

papillomavirus infections

,

papillomaviridae

,

uterine cervical neoplasms

catheterization

,

,

communicable diseases

,

,

,

healthy volunteers/patients

,

ventilator-associated pneumonia

,

wounds and injuries

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use